Today: 19 May 2026
Rivian stock slips again in premarket after CEO share-sale disclosure, with Tesla deliveries next
31 December 2025
1 min read

Rivian stock slips again in premarket after CEO share-sale disclosure, with Tesla deliveries next

NEW YORK, December 31, 2025, 06:05 ET — Premarket

  • Rivian shares were down about 0.9% in premarket trading after a 5.2% slide in the prior session.
  • A regulatory filing showed CEO R.J. Scaringe sold 17,450 shares under a pre-arranged trading plan.
  • Traders are watching Tesla’s delivery report and Rivian’s quarter-end production and delivery update for demand signals.

Rivian Automotive shares were down about 0.9% in premarket trading on Wednesday at $19.42, after the stock fell 5.2% in the previous session.

The decline has kept focus on an insider-trading disclosure that surfaced as markets moved into the year’s final, lower-liquidity stretch, when smaller orders can move prices more than usual.

That matters now because Rivian’s stock has been a high-volatility trade, and investors are sensitive to signals around funding risk and demand trends across the electric-vehicle sector.

Insider sales can weigh on sentiment because some investors interpret them as a confidence signal, even when the transactions were scheduled in advance and are not tied to fresh company developments.

A Form 4 filing showed Chief Executive Officer R.J. Scaringe sold 17,450 shares on Dec. 23 at a weighted average price of $21.4253 in transactions ranging from $21.21 to $21.69, and said the sale was made under a Rule 10b5-1 plan, a pre-arranged trading program that sets trades ahead of time.

Rule 10b5-1 plans are designed to reduce concerns that executives are trading based on material nonpublic information, but the headline “insider sale” can still pressure crowded trades.

Rivian’s slide has also come as investors look for near-term reads on EV demand. Tesla is expected to report lower fourth-quarter deliveries on Friday, after the loss of U.S. tax credits and heavier competition, Reuters reported.

Broader markets have been prone to abrupt rotations in holiday-thin trade. “It’s just a healthy rebalancing of allocations,” Mark Hackett, chief market strategist at Nationwide, said in a Reuters report on Tuesday’s session. https://www.reuters.com/business/us-stock-…

For Rivian, investors have kept the spotlight on cash burn — how quickly the company spends cash to fund operations — and whether production efficiency and higher-margin software revenue can narrow losses.

The next company-specific checkpoint is Rivian’s quarterly production and delivery update, which the company has historically released shortly after the quarter ends, alongside timing for its results call.

On the chart, traders have been watching whether the shares can hold above Tuesday’s intraday low near $19.28 after opening around $20.68, levels that often become near-term support and resistance.

Stock Market Today

  • Yacktman Asset Management Cuts Alphabet Inc. Stake Amid Mixed Institutional Moves
    May 19, 2026, 2:13 PM EDT. Yacktman Asset Management LP reduced its stake in Alphabet Inc. (NASDAQ:GOOG) by 3.1% in Q4, selling 36,606 shares and holding 1,129,807 shares valued at $354.5 million, representing 5% of its portfolio. Other institutional investors showed varied activity with Brighton Jones LLC and Worldquant Millennium Advisors LLC increasing their holdings significantly. Alphabet's stock saw multiple analyst ratings, including 'outperform' and 'buy' with target prices ranging from $345 to $450, reflecting positive sentiment from firms like Scotiabank, TD Cowen, and Deutsche Bank. Institutional investors own 27.26% of Alphabet's shares. The stock remains a top focus amid ongoing trading by hedge funds and asset managers.

Latest articles

Why Recursion Stock Just Hit a 52-Week Low — and the FDA Update Traders Are Waiting For

Why Recursion Stock Just Hit a 52-Week Low — and the FDA Update Traders Are Waiting For

19 May 2026
Recursion Pharmaceuticals shares fell 2.2% to $2.825 Tuesday, hitting a 52-week low of $2.77, after reporting first-quarter revenue of $6.47 million, down from $14.75 million a year earlier. Net loss narrowed to $117.5 million. Early clinical data for REC-1245 showed no dose-limiting toxicities in 16 solid-tumor patients. The company ended March with $665.2 million in cash.
Wall Street’s Top Picks for U.S. Stocks as Yields Stay High

Wall Street’s Top Picks for U.S. Stocks as Yields Stay High

19 May 2026
U.S. stocks fell Tuesday as the 10-year Treasury yield reached its highest point since January 2025, pressuring growth shares. Nvidia drew the most attention ahead of its earnings, with options markets pricing in a possible $355 billion swing in value. Dell highlighted new AI infrastructure partnerships, while ServiceNow received a fresh Buy rating from Bank of America.
Nvidia’s Earnings Could Make or Break the AI Stock Trade

Nvidia’s Earnings Could Make or Break the AI Stock Trade

19 May 2026
Nvidia rose 0.8% ahead of its earnings report, while CoreWeave dropped 3.7% after Google and Blackstone announced a $5 billion U.S. AI cloud venture using Google’s custom TPUs. The new venture will offer 500 megawatts of data-center capacity by 2027. AMD and Micron also gained, but Microsoft and Broadcom slipped. Investors are watching whether Nvidia can maintain dominance as competition in AI inference intensifies.
Premium Bonds January 2026 draw date is set — here’s when NS&I results drop and why savers are rethinking
Previous Story

Premium Bonds January 2026 draw date is set — here’s when NS&I results drop and why savers are rethinking

XRP price today: Ripple-linked token slips as year-end trading thins — key levels before 2026
Next Story

XRP price today: Ripple-linked token slips as year-end trading thins — key levels before 2026

Go toTop